Gemcitabine works by affecting DNA metabolism and killing tumor cells to achieve the effect of treating malignant tumors.
Gemcitabine kills malignant tumor cells in the division stage by inhibiting the DNA metabolism of tumor cells, and it has a better therapeutic effect in lung cancer and pancreatic cancer, and it is often used in combination with platinum-based chemotherapeutic drugs, which kills the tumor cells through a different mechanism of action, and it can achieve a better therapeutic effect.
Gemcitabine also has many adverse effects, such as bone marrow suppression, liver and kidney function impairment, allergy, cardiopulmonary injury, etc., which need to be monitored regularly during the use of the drug.
Gemcitabine treatment of lung cancer and pancreatic cancer is unable to achieve a cure, so be careful to assess the efficacy of the treatment, once there is a progression, suggesting drug resistance, be careful to change the treatment program. The medication should be used under the guidance of a doctor, and should not be used blindly to avoid delaying the condition.